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Abstract The role of reactive oxygen species (ROS) generated 
by hypoxanthine/xanthine oxidase (HX/XO) in the induction of 
apoptosis was studied in the human fibroblast cell line WI38. 
Apoptosis but not necrosis was observed in proliferating 
fibroblasts after 48 h incubation with 1 mM HX and 0.05 U/ml 
XO. Induction of apoptosis was hindered by catalase. Cell-cycle 
analysis revealed a reduction of cells in the S/G2 phase 24 and 48 
h after stimulation, suggesting that ROS induce a Gl arrest in 
proliferating fibroblasts. This was supported by an accumulation 
of p53 and the cdk inhibitor p21 W A , 7 C I P 1 . Since apoptosis was 
not inducible in senescent fibroblasts our data indicate that ROS 
mainly induces apoptosis in proliferating cells. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Recent work indicates that oxidative stress is required in 
many instances for execution of the apoptotic program [1], 
such as in response to y-irradiation [2] and T N F [3]. More-
over, oxidative stress may be sufficient to induce apoptosis, as 
recent work has shown that agents that directly promote the 
production of reactive oxygen species, such as H 2 0 2 [4,5] and 
menadione [6], can trigger apoptosis in diverse systems. Sim-
ilarily, exogenous antioxidants have been reported to block 
apoptosis induced by tumor necrosis factor (TNF) [7], HIV 
[8], endotoxin [9], growth-factor withdrawal [10], and gluco-
corticoids [11]. 
On the other hand, several reports suggest that the primary 
mode of cell death induced by reactive oxygen species (ROS) 
is necrosis, not apoptosis. In chondrocyte cultures ROS, pro-
duced by the hypoxanthine/xanthine oxidase (HX/XO) sys-
tem, induced necrosis but not apoptosis [12] and hypoxia 
did not affect the induction of apoptosis in lymphoma cell 
lines by either dexamethasone or by serum withdrawal [13]. 
In order to test the prediction that ROS is involved in 
apoptotic cell death, we stimulated a human lung fibroblast 
cell line (WI38) with R O S produced by the HX/XO system. 
Apoptosis was determined by D N A laddering and by means 
of T U N E L reaction. The up-regulation of p53 and p21, both 
involved in cell-cycle regulation and apoptotic signalling, as 
well as the induction of a G l arrest, provide evidence that 
exogenously applied ROS induces apoptosis in human lung 
fibroblasts. 
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2. Materials and methods 
2.1. Cell culture 
The human fibroblast cell line WI38 was obtained from Serva (Hei-
delberg, Germany). The cells were cultured in Dulbecco's modified 
Eagle's medium (DMEM) purchased from Serva (Heidelberg, Ger-
many). The medium was supplemented with 10% fetal calf serum 
(FCS), penicillin/streptomycin and glutamine (Biochrom, Berlin, Ger-
many). The cells were incubated at 37°C in 5% CO2 atmosphere. 
2.2. Culture conditions for stimulation assays 
Cells (passage 26) were seeded in 10 cm Petri dishes at a density of 
1 X 106 cells/7 ml. After 48 h cells were incubated in culture medium 
containing different concentrations of hypoxanthine (Sigma, Tauf-
kirchen, Germany) and xanthine oxidase (Boehringer, Mannheim, 
Germany). Superoxide dismutase (Boehringer, from bovine erythro-
cytes, No. 567680) and catalase (Boehringer, from beef liver, No. 
106810) were used in a concentration of 500 U/ml. For subsequent 
molecular analyses the cells were removed from the dishes by trypsi-
nation or in case of protein lysate preparation by mechanical scraping. 
2.3. Determination of cell viability 
For determination of the number of viable cells, cells were removed 
by trypsination and stained with trypan blue (Sigma, Taufkirchen, 
Germany) and the number of viable and dead cells were determined 
by light microscopy. All experiments were performed in quadrupli-
cates. 
2.4. Western blot analysis 
Cells were lysed by freezing and thawing the cells 3 times followed 
by sonication. Then the lysates were boiled in sodium dodecyl sulfate 
(SDS)-gel sample buffer for 5 min. Protein (20 ug) was electrophoreti-
cally resolved on denaturating 12% polyacrylamide gels. Proteins were 
transferred to nitrocellulose membranes (Schleicher and Schull, Das-
sel, Germany) using a transblot apparatus (Phase, Liibeck, Germany). 
Non-specific interactions were blocked by pre-incubation of the mem-
branes with a milk powder suspension (10% dry milk in PBS). After 
incubation of the membranes with monoclonal antibodies the binding 
of antibodies was detected using the ECL system (Amersham). 
2.5. Immunprecipitation 
Cell lysates were adjusted to a protein concentration of 1 mg/ml. 
The lysates were precleared twice by addition of 15 ul of protein A 
agarose (Oncogene Sciences, Cambridge, MA) to 1 ml of the lysate, 
incubation for 1 h at 4°C and centrifugation for 20 min at 13 000Xg. 
Then, lysates were incubated for 1 h with the monoclonal antibody at 
a concentration of 1 ug/ml, followed by an additional incubation with 
20 ul of protein A agarose for 1 h. After centrifugation the pellet was 
washed twice with lysis buffer and once with 0.125 M Tris buffer. The 
pellet was resuspended in 50 ul of SDS-gel sample buffer and boiled 
for 5 min at 95°C. Samples were analysed according to the Western 
blot protocol. 
2.6. RT-PCR of WAF1 
For the molecular detection of WAF1 total RNA was isolated from 
the cells as described previously [14]. Reverse transcription was per-
formed using the SUPERSCRIPT TM 2 Rnase H Reverse Tran-
scriptase from Gibco (Berlin, Germany) according to the manufactur-
er's protocol. PCR was carried out using the primers 5'-
CAGGATCCTGTGGGCGGATTAGGGCT-3' and 5'AGGATC-
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Fig. 1. DNA integrity analysis of WI38 cells treated with different 
concentrations of ROS. Cells were treated with medium only (Con-
trol, lane A), 1 mM HX/0.05 U/ml XO (lane B), 1 mM HX/0.05 VI 
ml XO+catalase (lane C), or 1 mM HX/0.05 U/ml XO+catalase/ 
superoxide dismutase (lane D). DNA laddering was only observed 
in lane B, addition of catalase or catalase/superoxide dismutase in-
hibited DNA laddering (lanes C and D). 
CATGTCAGAA-CCGGCTGG-3', amplifying a 520 bp product, 
under the following conditions: 60 s at 94°C followed by 60 s 60°C 
and 60 s 72°C in a total of 30 cycles. The elongation was accom-
plished for a further 5 min at 72°C. 
2.7. DNA extraction for nucleosomal ladder 
Cells were digested in a solution of 5% Sarcosyl, 50 mM Tris, and 
10 mM EDTA containing 20 U of proteinase K at 50°C with shaking 
for 12 h. Digestion was continued for 1 h after addition of 10 (ig of 
Dnase-free RNAse. After digestion, DNA was extracted sequentially 
with phenol and phenol/chloroform/isoamyl alcohol and chloroform 
and then ethanol precipitated and resuspended in 10 mM Tris-HCl 
(pH 8.0)—1 mM EDTA. Electrophoresis was carried out on 10 (ig 
from each DNA sample on a 1.0% agarose gel containing 0.1 |xg/ml 
ethidium bromide and photographed under UV light. 
2.8. Apoptosis assay 
Apoptosis was determined by TUNEL reaction (TdT-mediated 
dUTP nick end labeling) using an in situ cell death detection kit 
(fluorescein) from Boehringer (Mannheim, Germany) according to 
the manufacturer's protocol. In all experiments cell viability was de-
termined by trypan blue staining. 
2.9. Proliferation assay 
The proliferation was determined by BrdU incorporation and sub-
sequent BrdU detection using a commercially available BrdU labeling 
and detection kit (Boehringer, Mannheim, Germany). The cells were 
processed according to the manufacturer's protocol. 
Fig. 2. A: Immunoprecipitation of p53 and Western blot analysis of 
p21wAFi/ciPi f r o m W I 3 g c e l l s treated with 1 mM HX/0.05 U/ml 
XO. p53 protein increased reaching a maximum 12 h after stimula-
tion. In RT-PCR an increase of WAF1/CIP1-RNA was detectable 
6 h after stimulation (B). Transcription of p21WAFl/CIPl showed 
an increase 12 h after stimulation reaching a maximum 24 h after 
stimulation. Results were reproducible in two other experiments. 
3. Results 
3.1. Induction of apoptosis in WI38 cells is dependent on 
oxygen radical concentration 
We have recently shown that the HX/XO system constantly 
releases ROS over a time period of 1 h [15] with a release of 
approximately 3(M10 nmol/ml/min using a concentration of 
1 m M H X and 0.05 U/ml XO. In order to determine the 
effects of ROS, WI38 cells were incubated with 1 m M 
HX/0.05 U XO. Apoptosis was determined by means of the 
T U N E L reaction. At a concentration of 1 m M HX/0.05 U 
XO apoptotic changes were observed in 40% of the cells after 
48 h (Table 1 and Fig. 1). In the presence of superoxide dis-
mutase the apoptotic changes were not inhibited, whereas 
catalase alone or catalase plus superoxide dismutase were 
able to inhibit apoptosis. In all experiments t rypan blue stain-
ing revealed that the number of dead cells did not differ sig-
Table 1 
Portion of dead cells and apoptotic cells in WI38 cell cultures stimulated with different concentrations of ROS 
Culture conditions 
Control (medium) 
+ 1 mM HX/0.05 U/ml XO 
+ 1 mM HX/0.05 U/ml XO+CAT 
+ 1 mM HX/0.05 U/ml XO+SOD 
+ 1 mM HX/0.05 U/ml XO+CAT+SOD 
Cell viability was determined by Trypan blue staining; apoptosis was determined by TUNEL reaction and subsequent FACS analysis. 
CAT: catalase (500 U/ml); SOD: superoxide dismutase (500 U/ml). 
All experiments were performed in quadruplicate; values in parentheses represent standard deviation. 
*P< 0.001 as compared to control; **P< 0.001 as compared to 1 mM HX/0.05 U/ml XO. 
Dead cells 
after 24 h 
(%) 
4.5 (1.8) 
26.1 (4.9)* 
8.6 (2.9)" 
23.6 (7.6) 
8.2 (2.1) 
Dead cells 
after 48 h 
(%) 
6.9 ( 1.7) 
44.6 ( 5.1)* 
7.1 ( 3.8)" 
45.4 (11.2) 
7.9 ( 3.6) 
Apoptotic fraction 
after 24 h 
(%) 
5.5 (2) 
19.5 (4.4)* 
7.2 (3.1)" 
18.9 (5.7) 
6.9 (3.3)** 
Apoptotic fraction 
after 48 h 
(%) 
6.4 (2.1) 
40.3 (6.3)* 
7.4 (3.5)** 
42.6 (9.8) 
7.5 (4.7)** 
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OD-values at 405 nm 
0,18 
0,17 
0,16 
0,15 
0,14 
0,13 
0,12 
0,11 
Fig. 3. Proliferation analysis of WI38 by BrdU incorporation analysis. Experiments were performed 8 times. Proliferation was markedly inhib-
ited by addition of 1 mM HX/0.05 U/ml XO (P< 0.001 as compared to control). These effects were reversed by addition of catalase or catalase 
+superoxide dismutase ( P < 0.001 as compared to 1 mM HX/0.05 U/ml XO). Superoxide dismutase alone did not inhibit the proliferation ar-
rest. Higher concentrations of ROS totally inhibited cell proliferation, whereas lower concentrations of ROS did not inhibit cell proliferation 
(P< 0.0001 and not significant, respectively). 
nificantly from the number of apoptotic cells, which implies 
that the majority of cell death was due to apoptotic and not 
necrotic changes (Table 1). 
3.2. ROS induce p53 and p21 (WAF1) in human fibroblasts 
Using 1 m M H X and 0.05 U/ml X O immunoprecipitation 
of p53 revealed an increase of p53 protein in WI38 cells reach-
ing a maximum 12 h after stimulation followed by a decrease 
at 24 h and 48 h (Fig. 2A). In RT -PCR an increase of W A F 1 -
m R N A was detectable 6 h after stimulation (Fig. 2B). Tran-
scription of p21 protein was shown by Western blotting show-
ing an increase of p21 12 h after stimulation reaching max-
imum levels at 24 h after stimulation (Fig. 2A). Addit ion of 
catalase markedly reduced the induction of p53 and p21. 
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Fig. 4. Cell-cycle analysis of WI38 (passage 26): medium (control, A), 1 mM HX/0.05 U/ml XO 24 h (B) and 48 h (C) after stimulation and 
48 h after stimulation with 1 mM HX/0.05 U/ml XO+catalase+superoxide dismutase (D). M l : apoptotic fraction, M2: G0/G1 fraction, M3: 
S fraction, M4: G2/M fraction. During 48 h the apoptotic fraction increased to 45%, whereas the S/G2/M fraction decreased from 20.5% to 
2.8%. The G0/G1 fraction was only marginally affected (decrease from 72% to 59%) indicating a Gl arrest. The ROS-mediated effects were 
blockable by addition of catalase and superoxide dismutase. The results were reproducible in two other independent experiments. 
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Fig. 5. Cell-cycle analysis of WI38 (passage 46): medium (control, A), 1 mM HX/0.05 U/ml XO 24 h (B) and 48 h (C) after stimulation and 
48 h after stimulation with 1 mM HX/0.05 U/ml XO+catalase+superoxide dismutase (D). Ml: apoptotic fraction, M2: G0/G1 fraction, M3: 
S fraction, M4: G2/M fraction. During 48 h the apoptotic fraction remained constant between 10% and 14%. Similarly the S/G2/M fraction 
and the GO/Gl fraction remained constant (between 4.2-6.1% and 81.5-82.9%, respectively). The results were reproducible in two other inde-
pendent experiments. 
3.3. ROS induces a temporary Gl arrest in human fibroblasts 
Determination of proliferation by BrdU incorporation re-
vealed that proliferation was markedly inhibited by the gen-
eration of ROS at 1 mM HX/0.05 U/ml XO (Fig. 3, P< 0.001 
as compared to negative control). Addition of catalase inhib-
ited these effects (P < 0.001 as compared to 1 mM HX/0.05 U/ 
ml XO), whereas superoxide dismutase did not influence the 
proliferation arrest induced by ROS (Fig. 3). In cell-cycle 
analysis a reduction of the cells in the S/G2 phase was ob-
served 24 h and 48 h after stimulation (1 mM HX/0.05 U/ml 
XO) whereas the Gl fraction remained constant, suggesting 
that cells were hindered to enter S-phase (Fig. 4). These 
changes were inhibited by addition of catalase. 
3.4. ROS does not induce apoptosis in senescent fibroblasts 
In order to evaluate whether ROS mainly induces apoptosis 
in proliferating cells, especially in S/G2 phase, WI38 from 
passage 46, which only has a small capacity to proliferate, 
was incubated with HX and XO. At a concentration of 
1 mM HX and 0.05 U/ml XO no apoptosis was observed. 
Trypan blue staining confirmed that also no necrosis had 
occurred since no significant differences in cell viability were 
observed (viable cells at 24 h: Control: 93.3%, 1 mM HX/0.05 
U/ml XO: 91.2%, viable cells at 48 h: Control: 91.8%, 1 mM 
HX/0.05 U/ml XO: 89.7% viable cells) Even cell cycle or p53 
protein expression was not affected by ROS, indicating that 
ROS mainly acts in proliferating cells (S/G2) (Fig. 5). 
4. Discussion 
Oxidative stress resulting from toxic effects of ROS plays an 
important role in the pathogenesis of a variety of diseases and 
important biological processes [16-19]. Toxic effects of reac-
tive oxygen metabolites, including the superoxide anion, the 
H2O2 and the hydroxyl radical involve chemical alterations in 
proteins, lipids, carbohydrates and nucleic acids [20-23]. Ox-
idants are able to produce DNA damage [24] that can cause a 
specific cellular response whereby the protein product of the 
tumor suppressor gene p53 accumulates to high levels [25]. 
This increase seems to be directly responsible for the arrest 
of cells in the Gl phase of the cell cycle or, in case of severe 
DNA damage, p53 is supposed to cause apoptosis [26]. To 
examine the effects of ROS on the cellular and molecular 
response of human fibroblasts concerning the p53-dependent 
induction of apoptosis we incubated human fibroblasts with 
ROS generated by the HX/XO system which has been studied 
extensively [15,27-30] and results in both, the univalent and 
divalent reduction of O2 resulting in the formation of 02~ 
and H2O2, respectively. In the presence of redox-active tran-
sition metals such as iron or copper the hydroxyl radical is 
generated via the Fenton-reaction. H 2 0 2 also seems to form 
the hydroxyl radical (HO ) intracellularly which appears to be 
the most likely free radical responsible for DNA damage [28]. 
The hypothesis of the clastogenic properties of H2O2 is also 
supported by the finding that superoxide dismutase did not 
protect from XO-induced apoptosis and that catalase, which 
eliminates H 2 0 2 to 0 2 and water, protected cells from apop-
tosis. 
Our studies suggest that ROS induces apoptosis rather than 
necrosis in human fibroblasts. As a consequence of DNA 
damage we were able to demonstrate an increase of the pro-
tein product of the tumor suppressor gene p53 reaching a 
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maximum 12 h after stimulation with 1 m M HX/0.05 U/ml 
X O . p53 is able to bind in a sequence specific manner to D N A 
and activates the transcription of other genes [31,32]. The cdk 
inhibitor WAF1/CIP1 represents such a gene and its expres-
sion is induced by p53 in the cellular response to D N A dam-
age [12,33]. Consequently the accumulation of p53 was fol-
lowed by an increase of p21W A F 1 /ciPi a n ( j resulted in a 
reduced proliferation rate of cells, which was due to a G l 
arrest, as demonstrated by cell-cycle analysis and apoptosis. 
Both these effects were blocked by the addition of catalase. 
Fibroblasts from passage 46, having almost no capacity to 
proliferate, were not influenced by ROS to undergo apoptosis. 
Also no changes in cell cycle or p53 expression were observed. 
This suggests that R O S acts via a p53 increase in the G l 
phase of proliferating cells. 
Thus far the induction of apoptosis by reactive oxygen me-
tabolites is controversially discussed. In human chondrocytes 
it has been shown that ROS generated by HX/XO induced 
necrosis of the cells, whereas nitric oxide induces apoptosis [1]. 
On the other hand, oxidative stress has been suggested to play 
a role as a common mediator of apoptosis [34] and some 
independent observations in diverse systems support the hy-
pothesis for a role of oxidative mechanisms in the induction of 
apoptosis [35,36]. In human tumors it has been shown that 
hypoxic regions with high radical generation correlate with 
apoptotic changes [37]. A further hint for this hypothesis is 
the apoptosis inhibitor molecule bcl-2. The antioxidant activ-
ity of bcl-2 strongly implicates an involvement of R O S in the 
induction of programmed cell death [38]. 
In conclusion our results suggest that R O S is able to induce 
apoptosis in proliferating human fibroblasts, acting in the G l 
phase of the cell cycle and increasing the p53 and 
p2iWAFi/ciPi p r o t e j n levels. Further studies will be required 
to clarify whether p53 is directly associated by redox processes 
involving the site-specific DNA-binding capacity [39] or 
whether p53 is indirectly increased by other factors, which 
are induced by oxidative stress. A possible candidate could 
be the nuclear factor kappa B which is known to be induced 
via free radical reactions and on its part activates as a tran-
scription factor p53 [40]. 
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